Differential effects of clivarin and heparin in patients undergoing hip and knee surgery for the generation of anti-heparin-platelet factor 4 antibodies

By Ahmad S.   Haas S.   Hoppensteadt D.A.   Lietz H.   Reid U.   Bender N.   Messmore H.L.   Misselwitz F.   Bacher P.   Gaikwad B.S.   Jeske W.P.   Walenga J.M.   Fareed J.  

Thrombosis Research, Vol. 108, Iss. 1, 2002-10 ,pp. : 49-55

Elsevier

Access to resources Recommend Favorite

Human Anti-heparin-Platelet Factor 4 Antibodies Are Capable of Activating Primate Platelets - Towards the Development of a HIT Model in Primates

By Ahmad S.   Jeske W.P.   Walenga J.M.   Aldabbagh A.   Iqbal O.   Fareed J.  

Thrombosis Research, Vol. 100, Iss. 1, 2000-10 ,pp. : 47-54

Elsevier

Access to resources Recommend Favorite

Development of a non-human primate sub-clinical model of heparin-induced thrombocytopenia: platelet responses to human anti-heparin-platelet factor 4 antibodies

By Untch B.   Ahmad S.   Messmore H.L.   Schultz C.L.   Ma Q.   Hoppensteadt D.A.   Walenga J.M.   Fareed J.  

Thrombosis Research, Vol. 106, Iss. 2, 2002-04 ,pp. : 149-156

Elsevier

Access to resources Recommend Favorite

Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia - The pathogenic role of IgG

By Untch B.   Ahmad S.   Jeske W.P.   Messmore H.L.   Hoppensteadt D.A.   Walenga J.M.   Lietz H.   Fareed J.  

Thrombosis Research, Vol. 105, Iss. 2, 2002-01 ,pp. : 117-123

Elsevier

Access to resources Recommend Favorite

Heparin–platelet factor 4 antibodies in intensive care patients: an observational seroprevalence study

By Levine Robert   Hergenroeder Georgene   Francis John   Miller Charles   Hursting Marcie  

Journal of Thrombosis and Thrombolysis, Vol. 30, Iss. 2, 2010-08 ,pp. : 142-148

Springer Publishing Company

Access to resources Recommend Favorite